GeneChem

Country
Canada
Краткое название
GeneChem
Headquarters
1 Westmount Square
Suite 800
Montréal, QC H3Z 2P9
CAN
Members of the board
John Clement, Élizabeth Douville, Inès Holzbaur
Stage of the project
Pre-IPO
Disease
Diabetes
Co-investing
Да
Technology
Bioengineering, Vaccines, Information Technologies, Cell Technologies, Homogeneous antibodies, Nanotechnology, Devices, Technologies, Pharmaceuticals, Chemistry
Minimum investment
32M USD